See Also: Benefits of HIV Treatment and Risks of Nontreatment
General Information About HIV Treatment
HIV Treatment Fact Sheets from AIDSInfo:
- HIV Treatment: The Basics
- When to Start Antiretroviral Therapy
- What to Start: Selecting a First HIV Regimen
- FDA-Approved HIV Medicines
- Drug Resistance
- HIV Medication Adherence
- Following an HIV Regimen: Steps to Take Before and After Starting HIV Medicines
General Materials from Other Sources:
- What Is Antiretroviral Therapy? (AIDS InfoNet) and Spanish version
- Taking Current Antiretroviral Drugs (AIDS InfoNet) and Spanish version
- Starting HIV Treatment (Poz)
- Questions to Ask Your Doctor Before Starting Treatment (AIDSmap)
- Starting, Monitoring, and Switching HIV Treatment (Avert)
- First Steps to HIV/AIDS Treatment (TheBody)
- Personal Tracking Charts (Project Inform) – simple charts for tracking T-cell counts, viral load, medications, and other important health information
Selected Recent Articles
- Educational attainment associated with health outcomes after starting HIV therapy. (October 2016, AIDSmap)
- Dolutegravir plus lamivudine dual therapy works well as initial HIV treatment. (July 2016, AIDSmap); related coverage from MedPage Today
- Starting treatment on the day of HIV diagnosis improves retention and viral suppression, Haiti study shows. (July 2016, AIDSmap)
- Session reviews questions, controversies regarding initiation of ART in 2016. (July 2016, Healio)
- Newly initiated ART does not reduce arterial inflammation in HIV patients. (June 2016, Healio)
- Which HIV Treatment Regimens Are Recommended for Newly Diagnosed Patients? (June 2016, TheBodyPro)
- People not taking HIV treatment feel under pressure to ‘do the right thing’. (April 2016, AIDSmap)
- Starting HIV Treatment May Improve Liver Health. (March 2016, Poz)
- Starting HIV treatment at first clinic visit improves outcomes in African study. (February 2016, AIDSmap)
- Treating HIV Immediately May Protect Against Cognitive Decline. (January 2016, Poz)
- Start – and continue – HIV meds as soon as you can. (January 2016, Beta Blog)
- Slower Immune Recovery for Rapid Progressors Starting HIV Meds. (December 2015, Poz)
- Low Vitamin D May Drag CD4 Recovery When Starting HIV Meds. (December 2015, Poz)
- Times to Starting Treatment and Viral Suppression Drop 40% in U.S. Group, but Slower for African Americans. (December 2015, TheBodyPro)
- START sub-studies show no differences in lung or neurocognitive function with early or later treatment. (October 2015, AIDSmap)
- START sub-study shows more bone loss with earlier HIV treatment. (October 2015, AIDSmap)
- With EACS release, all international HIV treatment guidelines agree on when to start – for the first time since 2006. (October 2015, AIDSmap)
- Benefits of early HIV treatment are clear, but issues raised by START and D:A:D remain unresolved. (October 2015, AIDSmap)
- How do we treat the world? Experts discuss moving to universal HIV treatment. (October 2015, AIDSmap)
- New antiretrovirals and HIV treatment strategies highlighted at ICAAC. (October 2015, AIDSmap)
- Starting HIV Treatment for Newly Diagnosed Patients. (October 2015, TheBodyPro)
- Which HIV Treatment Regimen to Start with in 2015. (September 2015, TheBodyPro)
- 6 Overlooked Questions That May Hold the Key to Beating HIV. (April 2015, TheBodyPro)
- Dolutegravir Shows Promise as Part of First-Line HIV Therapy. (March 2015, Beta Blog)
- Starting HIV treatment at CD4 count above 500 reduces the risk of serious illness and death by 44%, African Temprano trial shows. (February 2015, AIDSmap)
- Early HIV Treatment Advantage Is Lost If Treatment Is Interrupted. (February 2015, Poz)
- Starting HIV treatment early and then interrupting is no better than delaying it. (January 2015, AIDSmap)
- First Year After HIV Infection Is Key Window for Treatment Start. (January 2015, Poz)
- The Treatment Divide: When’s the Best Time to Start HIV Meds? (November 2014 for Poz)
- Excellent outcomes among people starting HIV therapy at high CD4 counts in Uganda. (August 2014, AIDSmap)
- Selzentry (Maraviroc) Fails to Best Truvada as First-Line Therapy. (July 2014, Poz)
- Successful ART Started Under Age 6 Months More Likely to Yield Negative Antibody Test. (July 2014, NATAP)
- Good Response and Resistance Record in Naive and Experienced Starting Dolutegravir. (July 2014, NATAP)
- Therapy with newer, safer antiretrovirals an option for the majority of HIV-positive patients. (July 2014, AIDSmap)
- Low vitamin D concentrations associated with poor clinical and virological outcomesamong people starting HIV therapy. (May 2014, AIDSmap)
- Average CD4 cell count at time HIV therapy was started increased among young people in New York City after 2009. (January 2014, AIDSmap)
- Starting antiretroviral therapy significantly reduces the risk of decompensated liver disease for men with HIV/HCV co-infection. (December 2013, AIDSmap)
- Dolutegravir matches or surpasses other regimens for first-line HIV treatment. (October 2013, AIDSmap)
- Why Patients (and Their Clinicians) Choose Not to Start HIV Treatment. (October 2013, TheBodyPro)
- Insufficient Evidence to Support Universal HIV Treatment? (August 2013, Poz)
- Low baseline CD4 cell count associated with greater bone loss after starting HIV therapy. (August 2013, AIDSmap)
- CD4s at Entry Into HIV Care Largely Unchanged in 20 Years. (August 2013, Poz)
- CD4 cell count at time of entry to HIV care did not increase significantly between 1992 and 2011. (August 2013, AIDSmap)
- ‘Option B+’ women are at increased risk of loss to follow-up after starting HIV treatment. (July 2013, AIDSmap)
- First-line antiretroviral therapy has improved over time, meta-analysis shows. (July 2013, AIDSmap)
- German researchers report case of ‘functional cure’ after very early HIV treatment. (July 2013, AIDSmap)
- WHO issues new HIV recommendations calling for earlier ARV initiation. (June 2013, AIDSmap)
- Life expectancy for South African patients who start HIV therapy with CD4 cell counts above 200 is ‘near normal.’ (April 2013, AIDSmap)
- HIV Self-Testing and ART Initiation at Home: Promising Results from Blantyre Malawi. (March 2013, Science Speaks Blog)
- Lusaka study: Starting antiretroviral treatment keep patients coming back. (March 2013, Science Speaks Blog)
- Meta-analysis shows superiority of integrase inhibitors in first-line HIV therapy and benefits for people changing treatment due to resistance. (February 2013, AIDSmap)
- Systematic review confirms that efavirenz is a safer option than nevirapine for adults and children starting HIV therapy. (January 2013, AIDSmap)